Abstract:Objective: To investigate the effect of the TLR4/MyD88/NF-κB (Toll-like receptor 4/myeloid differentiation factor/nuclear factor kappa B) signalling pathway on the protective effect of ulinastatin on the intestinal mucosal barrier in mice with sepsis. Methods: A mouse model of sepsis was established by classical caecal ligation and perforation. Forty-four SPF C57BL/6 mice were randomly divided into the following four groups with 11 mice in each group: the control group (Con group), ulinastatin group (Uti group), Uti + LPS (lipopolysaccharide, LPS) group (Uti + LPS group) and LPS group. Mice in the Con group and Uti group received saline or ulinastatin injected 2 h after modelling; Mice in the Uti + LPS group received LPS injected 0 h after modelling, other procedures were the same as in the Uti group; Mice in the LPS group received LPS only. At 48 h after surgery, the levels of TNF-α (tumour necrosis factor-α, TNF-α), IL-6 (interleukin-6, IL-6) and IL-1β (interleukin-1β, IL-1β) in vein, and the expression of TLR4, MyD88 and NF-κB mRNA in small intestinal mucosa tissues using ELISA and RT‒PCR. Results: The pathological specimens showed increased inflammatory injury in the Con and LPS groups, while these injuries and changes improved in the Uti group. The scores of intestinal mucosal injury at 48 h of Uti injection were significantly lower than those of the Con group (P < 0.001), while the scores of intestinal mucosal injury of Uti + LPS were significantly higher than those of the Uti group (P = 0.044). The expression of TNF-α, IL-6 and IL-1β in the Uti decreased significantly at 48 h after surgery than that in the Con group (P = 0.001, P = 0.014, P = 0.004), while the expression of TNF-α, IL-6 and IL-1β in the Uti + LPS group increased significantly after surgery than that in the Uti group (P = 0.026, P = 0.040, P = 0.039). The expression of TLR4, MyD88 and NF-κB mRNA in the Uti group decreased significantly compared with that in the Con group (P = 0.001, P = 0.021, P = 0.007), while the expression of TLR4, MyD88 and NF-κB mRNA in the Uti + LPS group was higher than that in the Uti group (P = 0.023, P = 0.040, P = 0.045). Conclusion: These findings indicate that the protective effect of ulinastatin on the intestinal mucosal barrier against sepsis may be mediated through the TLR4/MyD88/NF-κB pathway.

Role of Using Two-Route Ulinastatin Injection to Alleviate Intestinal Injury in Septic Rats

Intraintestinal administration of ulinastatin protects against sepsis by relieving intestinal damage.

Protective Effect of Ulinastatin on Intestinal Barrier Function of Septic Rats

Beneficial effects of ulinastatin on gut barrier function in sepsis

Early Peritoneal Lavage with Ulinastatin Improves Outcome and Enhances Multi-Organ Protection in a Model of Severe Acute Pancreatitis.

Ulinastatin Enhances the Therapeutic Effect of Intraperitoneal Lavage on Severe Acute Pancreatitis in Rats

Ulinastatin Improves Survival of Septic Mice by Suppressing Inflammatory Response and Lymphocyte Apoptosis.

Protective Effects of Ulinastatin Combined With Thrombomodulin Against Lipopolysaccharide Induced Liver and Kidney Injury in Septic Rats

Thymosin Alpha(1)- and Ulinastatin-Based Immunomodulatory Strategy for Sepsis Arising from Intra-Abdominal Infection Due to Carbapenem-Resistant Bacteria

The role of TLR4/MyD88/NF-κB in the protective effect of ulinastatin on the intestinal mucosal barrier in mice with sepsis

Ulinastatin attenuates liver injury and inflammation in a cecal ligation and puncture induced sepsis mouse model

Ulinastatin is a novel candidate drug for sepsis and secondary acute lung injury, evidence from an optimized CLP rat model

Urinary Trypsin Inhibitor Treatment Ameliorates Acute Lung and Liver Injury Resulting from Sepsis in A Rat Model

Effect of Peritoneal Lavage with Ulinastatin on the Expression of NF-κB and TNF-α in Multiple Organs of Rats with Severe Acute Pancreatitis.

A retrospective study of the effectiveness of ulinastatin in the treatment of sepsis

[Effect of ulinastatin on serum levels of tumor necrosis factor-α, P-selectin, and thrombin-antithrombin complex in young rats with sepsis].

Protective effects of ulinastatin on acute lung injury resulting from sepsis in rat model

The Protective Effect of Ulinastatin on the Intestinal Mucosal Barrier in Rats after Intestinal Ischemia-Reperfusion

Impact of ulinastatin on survival and lymphocyte apoptosis in septic mice

Protective Effect of Urinary Trypsin Inhibitor on Septic Rat Lungs

Ulinastatin Improves Renal Microcirculation by Protecting Endothelial Cells and Inhibiting Autophagy in a Septic Rat Model